Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients.
Pharmacogenetics and genomics 2014 May 24 (5): 256-62.
Woillard Jean-Baptiste, Picard Nicolas, Thierry Antoine, Touchard Guy, Marquet Pierre,
UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.
Clinical pharmacology and therapeutics 2009 May 85 (5): 495-500.
Prausa S E, Fukuda T, Maseck D, Curtsinger K L, Liu C, Zhang K, Nick T G, Sherbotie J R, Ellis E N, Goebel J, Vinks A